» Articles » PMID: 28272074

When Potion Becomes Poison! A Case Report of Flecainide Toxicity

Overview
Journal J Postgrad Med
Specialty General Medicine
Date 2017 Mar 9
PMID 28272074
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We report a 48-day-old female infant, who developed cardiac conduction abnormalities and seizures secondary to supratherapeutic doses of oral flecainide. Flecainide was started in this infant for treatment of supraventricular tachycardia. The drug was withdrawn with successful normalization of the QRS complex and no further recurrence of seizures. The Naranjo probability score for adverse drug reaction was 8, making the causality "probable." The case restates an important message that physicians should be aware of the side effects of the drugs that they prescribe, especially of those drugs which have a narrow therapeutic window.

Citing Articles

Flecainide toxicity with pill-in-pocket approach from accidental overdose: a case report.

Oudih M, Ginsburg A, Hakim M, Zou F, Guttenplan N Eur Heart J Case Rep. 2024; 8(10):ytae522.

PMID: 39434856 PMC: 11493246. DOI: 10.1093/ehjcr/ytae522.


Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error.

Seltzer J, Schneir A J Med Toxicol. 2024; 20(3):314-323.

PMID: 38992232 PMC: 11288226. DOI: 10.1007/s13181-024-01018-9.


A rare case of flecainide-induced encephalopathy.

Wong E, Wu M HeartRhythm Case Rep. 2024; 10(3):201-202.

PMID: 38496743 PMC: 10943541. DOI: 10.1016/j.hrcr.2023.12.008.

References
1.
Russell G, Martin R . Flecainide toxicity. Arch Dis Child. 1989; 64(6):860-2. PMC: 1792554. DOI: 10.1136/adc.64.6.860. View

2.
Ferlini M, Colli A, Bonanomi C, Salvini L, Galli M, Salice P . Flecainide as first-line treatment for supraventricular tachycardia in newborns. J Cardiovasc Med (Hagerstown). 2009; 10(5):372-5. DOI: 10.2459/JCM.0b013e328329154d. View

3.
Chedoe I, Molendijk H, Dittrich S, Jansman F, Harting J, Brouwers J . Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literature. Drug Saf. 2007; 30(6):503-13. DOI: 10.2165/00002018-200730060-00004. View

4.
Ghika J, Goy J, Naegeli C, Regli F . Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy. Schweiz Arch Neurol Psychiatr (1985). 1994; 145(1):4-6. View

5.
Kohli V . Oral flecainide is effective in management of refractory tachycardia in infants. Indian Heart J. 2013; 65(2):168-71. PMC: 3861071. DOI: 10.1016/j.ihj.2013.02.009. View